References
- Jaffe IA. Comparison of the effect of plasmapheresis and penicil-lamine on the level of circulating rheumatoid factor. Ann Rheum Dis 1963;22:71–6.
- Wallace DJ, Goldfinger D, Gatti R, Lowe C, Fan P, Bluestone R, et al. Plasmapheresis and lymphoplasmapheresis in the manage-ment of rheumatoid arthritis. Arthritis Rheum 1979;22:703–10.
- Karsh J, Wright DG, Klippel JH, Decker JL, Deisseroth AB, Bye MW. Lymphocyte depletion by continuous flow cell centrifugation in rheumatoid arthritis: clinical effects. Arthritis Rheum 1979;22: 1055–9.
- Wright DG, Karsh J, Fauci AS, Klippel JH, Decker JL, O'Donnell JF, et al. Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation. Blood 1981;58:451–8.
- Trentham DE, Belli JA, Anderson RJ, Buckley JA, Goetzl EJ, David JR, et al. Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Engl J Med 1981;305:976–82.
- Paulus HE, Machleder HI, Levine S, Yu DT, MacDonald NS. Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum 1977;20:1249–62.
- Sirchia G, Rebulla P, Parravicini A, Carnelli V, Gianotti GA, Bertolini F. Leukocyte depletion of red cell units at the bedside by transfusion through a new filter. Transfusion 1987;27:402–5.
- Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Kataharada K, Ishizuka T, et al. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1999;42:431–7.
- Ueki Y, Yamasaki S, Kanamoto Y, Kawazu T, Yano M, Matsumoto K, et al. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Ftheumatology (Oxf) 2000;39:165–71.
- Ueki Y, Eguchi K. Leukocytapheresis for therapy of rheumatoid arthritis (in Japanese). Nippon Ftinsho 2005;63 Suppl 1:649–52.
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
- Steinbrocker 0, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659–62.
- Quinn MA, Conaghan PG, Emery P. The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? Ftheumatology (Oxf) 2001;40:1211–20.
- Nell VP, Machold KP, Ebert G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Ftheumatology (Oxf) 2004;43:906–14.
- van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004;50:2113–21.